# Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism

> **NCT02029456** · PHASE4 · UNKNOWN · sponsor: **Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** 25 mg Actilyse ( Boehringer Ingelheim, Germany) infusion in 6 hours

## Key facts

- **NCT ID:** NCT02029456
- **Lead sponsor:** Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2014-03
- **Final completion:** 2014-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02029456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02029456, "Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02029456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*